0001809726-20-000001.txt : 20200427 0001809726-20-000001.hdr.sgml : 20200427 20200427103604 ACCESSION NUMBER: 0001809726-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200427 DATE AS OF CHANGE: 20200427 EFFECTIVENESS DATE: 20200427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Claris Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001809726 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365789 FILM NUMBER: 20817765 BUSINESS ADDRESS: STREET 1: 299 PAVONIA AVENUE 3-8 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 201-344-7638 MAIL ADDRESS: STREET 1: 299 PAVONIA AVENUE 3-8 CITY: JERSEY CITY STATE: NJ ZIP: 07302 D 1 primary_doc.xml X0708 D LIVE 0001809726 Claris Biotherapeutics, Inc. 299 PAVONIA AVENUE 3-8 JERSEY CITY NJ NEW JERSEY 07302 201-344-7638 DELAWARE None None Corporation true 2018 Anton Clarke Atwell c/o Claris Biotherapeutics, Inc. 299 Pavonia Avenue 3-8 Jersey City NJ NEW JERSEY 07302 Executive Officer Director Reza Dana c/o Claris Biotherapeutics, Inc. 299 Pavonia Avenue 3-8 Jersey City NJ NEW JERSEY 07302 Director Kenneth Harrison c/o Claris Biotherapeutics, Inc. 299 Pavonia Avenue 3-8 Jersey City NJ NEW JERSEY 07302 Director Biotechnology Decline to Disclose 06b false 2020-04-13 false true false 0 25999999 11846938 14153061 false 1 0 0 0 false Claris Biotherapeutics, Inc. /s/ Anton Clarke Atwell Anton Clarke Atwell President and Chief Executive Officer 2020-04-17